RETROVIRUSES AND IMMUNOSUPPRESSION: PREVENTION AND THERAPY NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


RETROVIRUSES AND IMMUNOSUPPRESSION: PREVENTION AND THERAPY

Eighteenth Meeting of the European Tumor Virus Group. April 30-May 4, 1989, Sundbyholm's Castle, Sweden, Swedish Cancer Society, 1989.. Unique Identifier : AIDSLINE ICDB/90660590
Anonymous; No affiliation given

Abstract: Abstracts are presented for the 18th European Tumor Virus Group meeting held April 30-May 4, 1989, in Sweden. Titles for the portion of the meeting covering retroviruses and immunosuppression (prevention and therapy) include isolation of an inhibitor of retrovirus multiplication; highly protective cell-derived vaccine against bovine leukemia virus (BLV) infection; retrovirus-related gene products in human cells and tissues; lytic infection and transformation of human diploid fibroblasts by a polyoma virus isolated from a healthy donor; analysis of HIV-1 neutralization escape mutants; BLV immunostimulating complexes (biochemical characterization); expression of the BLV env gene by genetically engineered vaccinia virus recombinants; inhibition of the processing of HIV-protein precursors by a renin-inhibitor synthetic peptide; effect of antiviral, cancerostatic, and anticoagulant substances on reverse transcriptase of different retroviruses; and structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with Foscarnet on HIV-1.
Keywords: Animal Antiviral Agents/ADMINISTRATION & DOSAGE Cell Line, Transformed Cytopathogenic Effect, Viral/*IMMUNOLOGY Gene Expression Regulation, Viral/*PHYSIOLOGY Human HIV/IMMUNOLOGY HIV Infections/IMMUNOLOGY Retroviridae/*GENETICS MONOGRAPHKWDanimalantiviralagents/administration&dosagecellline,transformedcytopathogeniceffect,viral/KWDimmunologygeneexpressionregulation,viral/KWDphysiologyhumanhiv/immunologyhivinfections/immunologyretroviridae/KWDgeneticsmonograph
900530
M9051009

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .